Kent Jardemark
Karolinska Institutet, Stockholm, Sweden
In presentations
Saturday, June 27, 01:20 PM – 01:20 PM
Development of novel add-on treatment of cognitive dysfunction in schizophrenia
Speaker: Kent Jardemark (Karolinska Institutet, Physiology and Pharmacology, Stockholm, Sweden)
Saturday, June 27, 01:20 PM – 01:20 PM
The effect of kynurenic acid (KYNA) release on glutamatergic transmission in the hippocampus - a model of schizophrenia
Speaker: Kent Jardemark (Karolinska Institutet, Physiology and Pharmacology, Stockholm, Sweden)